These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 24068565)

  • 21. MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling.
    Ni Q; Zhang Y; Tao R; Li X; Zhu J
    Aging (Albany NY); 2021 Mar; 13(6):8665-8687. PubMed ID: 33714198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY; Li N; Cui YL
    Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells.
    Li C; Zou J; Zheng G; Chu J
    Med Sci Monit; 2016 Nov; 22():4509-4515. PubMed ID: 27876712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ethoxysanguinarine directly targets CIP2A to inhibit proliferation and induce autophagy of SGC7901/DDP cells].
    Wan F; Tan M; Xiang YC; Liu XW; Peng P; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5890-5899. PubMed ID: 36472008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of miR-34a Promotes Proliferation and Inhibits Apoptosis of Rat Osteoarthritic Cartilage Cells by Activating PI3K/Akt Pathway.
    Tao H; Cheng L; Yang R
    Clin Interv Aging; 2020; 15():373-385. PubMed ID: 32214804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin Promoted miR-34a Expression and Suppressed Proliferation of Gastric Cancer Cells.
    Sun C; Zhang S; Liu C; Liu X
    Cancer Biother Radiopharm; 2019 Dec; 34(10):634-641. PubMed ID: 31539270
    [No Abstract]   [Full Text] [Related]  

  • 27. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.
    Zhu QL; Li Z; Lv CM; Wang W
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin.
    Peng Y; Fan JY; Xiong J; Lou Y; Zhu Y
    Pathobiology; 2019; 86(5-6):296-305. PubMed ID: 31711057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
    Lian G; Li L; Shi Y; Jing C; Liu J; Guo X; Zhang Q; Dai T; Ye F; Wang Y; Chen M
    Int J Oncol; 2018 Mar; 52(3):804-814. PubMed ID: 29393385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer.
    Yang KD; Wang Y; Zhang F; Li QL; Luo BH; Feng DY; Zeng ZJ
    Mol Cell Biochem; 2022 Nov; 477(11):2493-2505. PubMed ID: 35588343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
    Hu J; Fang Y; Cao Y; Qin R; Chen Q
    Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells.
    Yang B; Huang J; Liu H; Guo W; Li G
    Tumour Biol; 2016 Feb; 37(2):1771-9. PubMed ID: 26318298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of PLK1 inhibition on cisplatin-resistant gastric cancer cells.
    Chen Z; Chai Y; Zhao T; Li P; Zhao L; He F; Lang Y; Qin J; Ju H
    J Cell Physiol; 2019 May; 234(5):5904-5914. PubMed ID: 30488440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [miR-34a-5p regulates viability, invasion and apoptosis of placental trophoblastic cells
    Li Q; Xu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):79-86. PubMed ID: 32376568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
    Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
    Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted Regulation of FoxO3a by miR-372 to Mediate Gastric Carcinoma Cell Apoptosis and DDP Drug Resistance.
    Wang C; Wang C; Qiu C; Su Z
    Cancer Biother Radiopharm; 2020 Dec; 35(10):753-759. PubMed ID: 32379491
    [No Abstract]   [Full Text] [Related]  

  • 40. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.